WallStSmart

General Motors Company (GM)vsThermo Fisher Scientific Inc (TMO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

General Motors Company generates 308% more annual revenue ($184.62B vs $45.20B). TMO leads profitability with a 15.1% profit margin vs 1.4%. GM appears more attractively valued with a PEG of 0.34. TMO earns a higher WallStSmart Score of 62/100 (C+).

GM

Buy

52

out of 100

Grade: C-

Growth: 3.3Profit: 4.5Value: 8.0Quality: 4.3
Piotroski: 3/9Altman Z: 1.19

TMO

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 4.0Quality: 5.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GMUndervalued (+24.0%)

Margin of Safety

+24.0%

Fair Value

$105.05

Current Price

$78.80

$26.25 discount

UndervaluedFair: $105.05Overvalued
TMOSignificantly Overvalued (-16.1%)

Margin of Safety

-16.1%

Fair Value

$408.60

Current Price

$465.00

$56.40 premium

UndervaluedFair: $408.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GM4 strengths · Avg: 9.3/10
PEG RatioValuation
0.3410/10

Growing faster than its price suggests

Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Market CapQuality
$70.70B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.44B8/10

Generating 1.4B in free cash flow

TMO1 strengths · Avg: 9.0/10
Market CapQuality
$176.32B9/10

Large-cap with strong market position

Areas to Watch

GM4 concerns · Avg: 3.3/10
P/E RatioValuation
28.6x4/10

Moderate valuation

Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Profit MarginProfitability
1.4%3/10

1.4% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

TMO3 concerns · Avg: 3.7/10
PEG RatioValuation
1.564/10

Expensive relative to growth rate

P/E RatioValuation
26.1x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : GM

The strongest argument for GM centers on PEG Ratio, Price/Book, Market Cap. PEG of 0.34 suggests the stock is reasonably priced for its growth.

Bull Case : TMO

The strongest argument for TMO centers on Market Cap. Profitability is solid with margins at 15.1% and operating margin at 17.9%.

Bear Case : GM

The primary concerns for GM are P/E Ratio, Return on Equity, Profit Margin. Thin 1.4% margins leave little buffer for downturns.

Bear Case : TMO

The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

GM profiles as a value stock while TMO is a mature play — different risk/reward profiles.

GM carries more volatility with a beta of 1.29 — expect wider price swings.

TMO is growing revenue faster at 6.2% — sustainability is the question.

GM generates stronger free cash flow (1.4B), providing more financial flexibility.

Bottom Line

TMO scores higher overall (62/100 vs 52/100), backed by strong 15.1% margins. GM offers better value entry with a 24.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

General Motors Company

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

General Motors Company (GM) is an American multinational corporation headquartered in Detroit, Michigan that designs, manufactures, markets, and distributes vehicles and vehicle parts, and sells financial services, with global headquarters in Detroit's Renaissance Center.

Thermo Fisher Scientific Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Visit Website →

Want to dig deeper into these stocks?